Trial Outcomes & Findings for Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients (NCT NCT00423436)

NCT ID: NCT00423436

Last Updated: 2011-12-16

Results Overview

Total number of alerts generated by symptom exceeding prespecified threshold for 7 symptoms - pain, fatigue, nausea, cough, constipation, vomiting and shortness of breath (Ratio alerts/number of assessments using IVR telephone triage/feedback versus IVR only). Reporting 0-10 severity scale of MD Anderson Symptom Inventory from 0 (symptom not present) to 10 (symptom bad as imagine it could be). Thresholds set at 4 on scale for all symptoms except shortness of breath and constipation where threshold set at 2. More than one symptom alert may appear per assessment causing ratio values to exceed 1.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

84 participants

Primary outcome timeframe

Baseline to end of first chemotherapy cycle (generally chemotherapy and 1 assessment of response within 6-8 weeks)

Results posted on

2011-12-16

Participant Flow

Recruitment Period: 04/30/03 to 12/10/08. All participants recruited at UT MD Anderson Cancer Center.

Of 84 enrolled, 16 participants dropped out before baseline assessment, prior to group assignment. Baseline data analysis was done on the remaining 68 patients (35 in the intervention and 33 in the control group).

Participant milestones

Participant milestones
Measure
IVR Assessment Plus Triage
Interactive Voice Response Telephone System (IVR) Plus Triage (Participants report symptoms to telephone system and doctor/nurse notified when symptom is severe) + Questionnaire
IVR Assessment Only
IVR (Phone calls twice weekly) + Questionnaire
Overall Study
STARTED
35
33
Overall Study
COMPLETED
35
33
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
IVR Assessment Plus Triage
n=35 Participants
Interactive Voice Response Telephone System (IVR) Plus Triage (Participants report symptoms to telephone system and doctor/nurse notified when symptom is severe) + Questionnaire
IVR Assessment Only
n=33 Participants
IVR (Phone calls twice weekly) + Questionnaire
Total
n=68 Participants
Total of all reporting groups
Age Continuous
64.41 years
STANDARD_DEVIATION 9.11 • n=5 Participants
60.63 years
STANDARD_DEVIATION 8.40 • n=7 Participants
62.5762 years
STANDARD_DEVIATION 8.9158 • n=5 Participants
Sex: Female, Male
Female
18 Participants
n=5 Participants
18 Participants
n=7 Participants
36 Participants
n=5 Participants
Sex: Female, Male
Male
17 Participants
n=5 Participants
15 Participants
n=7 Participants
32 Participants
n=5 Participants
Region of Enrollment
United States
35 participants
n=5 Participants
33 participants
n=7 Participants
68 participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline to end of first chemotherapy cycle (generally chemotherapy and 1 assessment of response within 6-8 weeks)

Population: Analysis was per protocol. Due to attrition, data from 61 participants were analyzed at end of first chemotherapy cycle and from 27 participants at the end of the study.

Total number of alerts generated by symptom exceeding prespecified threshold for 7 symptoms - pain, fatigue, nausea, cough, constipation, vomiting and shortness of breath (Ratio alerts/number of assessments using IVR telephone triage/feedback versus IVR only). Reporting 0-10 severity scale of MD Anderson Symptom Inventory from 0 (symptom not present) to 10 (symptom bad as imagine it could be). Thresholds set at 4 on scale for all symptoms except shortness of breath and constipation where threshold set at 2. More than one symptom alert may appear per assessment causing ratio values to exceed 1.

Outcome measures

Outcome measures
Measure
IVR Assessment Plus Triage
n=100 Alerts
Interactive Voice Response Telephone System (IVR) Plus Triage (Participants report symptoms to telephone system and doctor/nurse notified when symptom is severe) + Questionnaire
IVR Assessment Only
n=200 Alerts
IVR (Phone calls twice weekly) + Questionnaire
Ratio of Number of Alerts Generated by Symptom Distress Over the Number of Available Assessments
0.96 Ratio of alerts/number of assessments
1.56 Ratio of alerts/number of assessments

Adverse Events

IVR Assessment Plus Triage

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

IVR Assessment Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Charles S Cleeland, PhD, Professor

UT MD Anderson Cancer Center

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place